Nigyan Zhang

Title: The Innovative Contributions of Nigyan Zhang

Introduction

Nigyan Zhang is a notable inventor based in Houston, Texas, recognized for his significant contributions to the field of biomedical research. His work primarily focuses on developing innovative methods for detecting amyloid beta oligomers, which are crucial in the study of Alzheimer's disease.

Latest Patents

Zhang holds a patent for his invention titled "Antibodies, kit and method for detecting amyloid beta oligomers." This invention features a selective Aβ oligomer kit and an immunoassay method that can reliably and sensitively detect Aβ oligomers in biological samples from patients. The assay employs a pair of anti-Aβ oligomer antibodies, serving as capture and detection antibodies, to accurately detect and quantify Aβ oligomers. This method is particularly valuable as it can differentiate Alzheimer's disease patients from non-Alzheimer's patients and stratify Alzheimer's patients according to the severity of their condition.

Career Highlights

Zhang is currently associated with Acumen Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact the diagnosis and treatment of Alzheimer's disease, providing new avenues for patient care.

Collaborations

Zhang collaborates with esteemed colleagues, including William F. Goure and Renee C. Gaspar, who contribute to the research and development of innovative solutions in the field of Alzheimer's disease.

Conclusion

Nigyan Zhang's innovative work in detecting amyloid beta oligomers represents a significant advancement in Alzheimer's research. His contributions are paving the way for improved diagnostic methods and better patient outcomes.